These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 131889)

  • 1. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.
    Goldstein AL; Cohen GH; Rossio JL; Thurman GB; Brown CN; Ulrich JT
    Med Clin North Am; 1976 May; 60(3):591-606. PubMed ID: 131889
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Effect of thymosin on B-lymphocyte function.
    Wara DW; Ammann AJ
    N Engl J Med; 1975 Sep; 293(10):507. PubMed ID: 1080248
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymosin activity in patients with cellular immunodeficiency.
    Wara DW; Goldstein AL; Doyle NE; Ammann AJ
    N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Thymosin therapy creates a "Hassall"(?).
    Hong R; Horowitz S
    N Engl J Med; 1975 Jan; 292(2):104-5. PubMed ID: 1078550
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
    Goldstein AL
    Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and properties of bovine thymosin.
    Hooper JA; McDaniel MC; Thurman GB; Cohen GH; Schulof RS; Goldstein AL
    Ann N Y Acad Sci; 1975 Feb; 249():125-44. PubMed ID: 236717
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of thymosin in lymphocyte maturation.
    Thurman GB; Goldstein AL
    Boll Ist Sieroter Milan; 1975 Jul; 54(3):203-10. PubMed ID: 1082758
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
    Goldstein AL; Thurman GB; Rossio JL; Costanzi JJ
    Transplant Proc; 1977 Mar; 9(1):1141-4. PubMed ID: 325742
    [No Abstract]   [Full Text] [Related]  

  • 10. The endocrine thymus: potential role for thymosin in the treatment of autoimmune disease.
    Goldstein AL; Thurman GB; Cohen GH; Rossio JL
    Ann N Y Acad Sci; 1976; 274():390-401. PubMed ID: 786112
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo responses to thymosin in severe combined immunodeficiency.
    Mawhinney H; Gleadhill VF; McCrea S
    Clin Immunol Immunopathol; 1979 Oct; 14(2):196-203. PubMed ID: 314879
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of thymosin activity.
    Marshall GD; Low TL; Thurman GB; Hu SK; Rossio JL; Trivers G; Goldstein AL
    Cancer Treat Rep; 1978 Nov; 62(11):1731-7. PubMed ID: 215305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of T-cells rosettes in immunodeficient patients by thymosin.
    Wara DW; Ammann AJ
    Ann N Y Acad Sci; 1975 Feb; 249():308-15. PubMed ID: 1079429
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases.
    Incefy GS; Boumsell L; Kagan W; Goldstein G; Sousa MD; Smithwick E; O'Reilly R; Good RA
    Trans Assoc Am Physicians; 1975; 88():135-45. PubMed ID: 772925
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of thymoptin in the specific immunotherapy of experimental microbial allergy].
    Sukhodoeva GS; Shamsutdinova GS; Andreeva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):58-9. PubMed ID: 8553760
    [No Abstract]   [Full Text] [Related]  

  • 16. Experiences with thymosin in primary immunodeficiency disease.
    Astaldi A; Astaldi GC; Wijermans P; Dagna-Bricarelli F; Kater L; Stoop JW; Vossen JM
    Cancer Treat Rep; 1978 Nov; 62(11):1779-85. PubMed ID: 215306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution.
    Steele RW; Britton HA; Anderson CT; Kniker WT
    Pediatr Res; 1976 Dec; 10(12):1003-5. PubMed ID: 995498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immune balance by thymosin: potential role in the development of suppressor T-cells.
    Goldstein AL; Cohen GH; Thurman GB; Hooper JA; Rossio JL
    Adv Exp Med Biol; 1976; 66():221-8. PubMed ID: 773116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological aberrations in purine nucleoside phosphorylase deficiencies.
    Ammann AJ
    Ciba Found Symp; 1978; (68):55-75. PubMed ID: 159164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.